Boule Diagnostics (Sweden) Today
| BOUL Stock | SEK 7.38 0.62 9.17% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Boule Diagnostics is selling for under 7.38 as of the 24th of November 2024; that is 9.17 percent increase since the beginning of the trading day. The stock's last reported lowest price was 6.5. Boule Diagnostics has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Boule Diagnostics AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of November 2023 and ending today, the 24th of November 2024. Click here to learn more.
Boule Diagnostics AB , a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. Boule Diagnostics AB was founded in 1956 and is headquartered in Spnga, Sweden. Boule Diagnostics operates under Image Processing classification in Sweden and is traded on Stockholm Stock Exchange.. The company has 38.83 M outstanding shares. More on Boule Diagnostics AB
Moving against Boule Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Boule Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Boule Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Boule Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) |
Boule Diagnostics AB (BOUL) is traded on Stockholm Exchange in Sweden and employs 200 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 532.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boule Diagnostics's market, we take the total number of its shares issued and multiply it by Boule Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Boule Diagnostics operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 38.83 M outstanding shares.
Boule Diagnostics AB has accumulated about 38.18 M in cash with 43.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.87.
Check Boule Diagnostics Probability Of Bankruptcy
Ownership AllocationBoule Diagnostics holds a total of 38.83 Million outstanding shares. Boule Diagnostics AB shows significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Boule Diagnostics AB stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Boule Ownership Details
Boule Diagnostics Risk Profiles
Although Boule Diagnostics' alpha and beta are two of the key measurements used to evaluate Boule Diagnostics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.44 | |||
| Standard Deviation | 3.43 | |||
| Variance | 11.77 | |||
| Risk Adjusted Performance | (0.01) |
Boule Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Boule Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Boule Diagnostics Corporate Management
Elected by the shareholders, the Boule Diagnostics' board of directors comprises two types of representatives: Boule Diagnostics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boule. The board's role is to monitor Boule Diagnostics' management team and ensure that shareholders' interests are well served. Boule Diagnostics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boule Diagnostics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Annette Colin | VP CFO | Profile | |
| Helena Borjesson | Chief Officer | Profile | |
| Karen Bornstein | North Marketing | Profile | |
| Aishat Bislieva | VP Culture | Profile | |
| Jesper Soderqvist | CEO Pres | Profile | |
| Mikael Ekholm | VP Production | Profile |
Additional Tools for Boule Stock Analysis
When running Boule Diagnostics' price analysis, check to measure Boule Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boule Diagnostics is operating at the current time. Most of Boule Diagnostics' value examination focuses on studying past and present price action to predict the probability of Boule Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boule Diagnostics' price. Additionally, you may evaluate how the addition of Boule Diagnostics to your portfolios can decrease your overall portfolio volatility.